Pharmacology Section DOI : 10.7860/JCDR/2015/14764.6807
Year : 2015 | Month : Nov | Volume : 9 | Issue : 11 Page : FC21 - FC24

Antibiotic Prescribing Pattern in a Tertiary Level Neonatal Intensive Care Unit

Sonali Suryawanshi1, Vijaya Pandit2, Pradeep Suryawanshi3, Aditi Panditrao4

1 Assistant Professor, Department of Pharmacology, Bharati Vidyapeeth Deemed University, Medical College Pune, India.
2 Professor and Head of Department, Department of Pharmacology, Bharati Vidyapeeth Deemed University, Medical CollegePune, India.
3 Professor and Head of Department, Department of Neonatology, Bharati Vidyapeeth Deemed University, Medical CollegePune, India.
4 Post Graduate Student, Department of Pharmacology, Bharati Vidyapeeth Deemed University, Medical CollegePune, India.

NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Sonali Suryawanshi, Assistant Professor, Department of Pharmacology, Bharati Vidyapeeth Deemed University Medical College, Katraj- Dhankawadi, Pune-411043, India.


Neonatal sepsis is a major cause of morbidity and mortality worldwide especially in developing countries, which justifies early diagnosis and prompt treatment with antibiotics. Antibiotics are the most frequently used medicines in Neonatal Intensive care units. Data regarding rational antibiotic use in neonates is very limited. Hence, it is essential that the antibiotic prescribing patterns be evaluated periodically for its rational use. Therefore, the present study been carried out to identify the prescribing patterns of antibiotics in neonatal intensive care unit of a tertiary care hospital, Western Maharashtra, India.

Materials and Methods

A prospective observational study was carried out for 6 months between April to September 2014. The data regarding patient demographics and antibiotic use was collected daily in a structured proforma. Collected data was subjected to statistical analysis.


Out of total 528 neonates with male preponderance (62%), 370 received antibiotics. Mean gestational age and birth weight were 35±3.2 weeks and 2±0.7 kg respectively. Mean length of hospital stay was 14.26±15.36 days (range 1 to 136 days). A total of 1123 antibiotics were prescribed to 370 neonates. The majority of neonates (55.9%) received between 1-2 antibiotics, 37.3% had 3 to 5 antibiotics prescribed, while 6.7% neonates were prescribed more than 5 antibiotics. Number of antibiotics used had statistically significant inverse relationship with gestational age. Among antibiotics; Amikacin, Cefotaxime and Levofloxacin were the drugs most often prescribed. Amikacin and Cefotaxime were given more to term infants whereas other antibiotics like Levofloxacin, Pipercillin- tazobactam and Meropenem were prescribed more to preterm and outborn neonates.


The use of a high number of antibiotics is a common practice. Although the indications for use of most antibiotics could be justified, the increased frequency of anbiotics use in some neonates was of concern. Guidelines for the use of antibiotics in neonates are required and larger studies are needed on this issue.


Antibiotics are the key drugs for treatment of infections and are among the most commonly prescribed drugs in neonatal intensive care unit (NICU) [1]. Worldwide population consists of about 28% children and infants who are most susceptible to infective diseases due to under developed immune system [2]. Several studies have reported that 50%-85% of children receive antibiotics prescribed by physicians [3]. In addition, neonates are among the most vulnerable population groups to contract infections [4] and are also prone to harmful effects of drugs due to differences in pharmacodynamic and pharmacokinetic characterstics [5].

The use of antimicrobial agents, especially antibiotics has become a routine practice for the treatment of neonatal illnesses [6]. Antibiotic guidelines are standard set of guidelines for the treatment of infectious diseases based on local culture sensitivity data. These guidelines help the physician to prescribe the antibiotics rationally to paediatric patients when definitely indicated (WHO model formulary for children, 2010) [7]. In spite of these, neonates are at high risk for opportunistic or nosocomial infections due to prolonged hospitalization and immunosuppressed condition [8]. An overall rise in health care costs, lack of uniformity in drug prescribing and the emergence of antibiotic resistance, are issues of monitoring and control of antibiotic use is of growing concern [9].

Thus, judicious use of antibiotic is an important way to reduce the problem of antimicrobial resistance. Hence, detailed rational knowledge of antibiotic prescribing pattern must be implemented in clinical practice. Neonates require more attention while prescribing antibiotics in order to avoid the drug resistance, adverse drug reactions and drug-drug interactions. Moreover, antibiotics are the class of drugs commonly prescribed in the NICU. Thus, the aim of our study was to observe and analyse the prescribing pattern of antibiotics in NICU of a tertiary care hospital in Western Maharashtra, India.

Materials and Methods

An observational and prospective study of six months duration was carried out in the NICU of a tertiary care hospital in Pune from April to September 2014. All the 528 neonates admitted to the NICU for more than 24 hours during the study period were included after the Institutional Ethics Committee approval. Neonates died or discharged within 24 hours of admission were excluded from the study. Study was carried out by evaluating medication records of admitted neonates. Data pertaining to gestational age, birth weight, gender, diagnosis, and patient outcome as percentages of survival, discharge and death were recorded. Details of antibiotics administered to each patient were recorded.

Statistical Analysis

The results were presented as percentage for categorical variables and mean±standard deviation for continuous variables. Chi-square test or Fisher’s exact was used to compare categorical data


A total of 528 neonates were included in the study with male preponderance (62%) and out born referrals, 64.2%. Among 528 admitted neonates, 246 (46.6%) were term and 282 (53.4%) were preterm. The mean gestational age was 35 weeks (SD ± 3.2, minimum= 23, maximum = 42). The mean birth weight was 2.0 kg. (SD ± 0.7, minimum 0.5 kg, maximum 4.0 kg). Twenty four deaths were recorded during study period. Neonatal jaundice, pneumonia, neonatal sepsis, perinatal asphyxia, prematurity were the common indications for admission in NICU [Table/Fig-1].

Disease pattern and patients’ outcome

DiseaseSurvival(%)DeathDORDAMAChi2 test value (df)p-value
Neonatal Jaundice191(88.8)5(2.3)4(1.7)15(7.0)4.3 (3)p = 0.224
Neonatal Sepsis55(70.51)12(15.4)@1(1.3)10(12.8)@30.5 (3)p < 0.001
Respiratory distress syndrome(RDS)47(73.4)11(17.2)@1(1.5)5(7.8)27.1 (3)p < 0.001
Perinatal Asphyxia64(92.8)1(1.5)0(0.0)4(5.8)3.9 (3)p = 0.372
Pneumonia91(85.1)6(5.6)2(1.9)8(7.5)0.40 (3)p = 0.921

@ Higher death rate was observed in these patients as compared to other patients

p<0.01using Chi-square test. Values in parenthesis are in percentages

Survival rate was highest in perinatal asphyxia, neonatal jaundice and pneumonia. Significanly more number of deaths were observed in the neonates with neonatal RDS and neonatal sepsis (p<0.05).

A total of 1123 antibiotics have been prescribed to 370 neonates. The majority of neonates 207 (55.9%) received between 1- 2 antibiotics, 138 neonates (37.3%) had 3 to 5 antibiotics prescribed, while 25 (6.7%) neonates were prescribed more than 5 antibiotics [Table/Fig-2].

Number of antibiotics received by the neonates

[Table/Fig-3] shows that more antibiotics were used in very preterm neonates with stastically significant negative association for number of antibiotics used with gestational age.

Number of antibiotics and gestational age

No. Antibiotics receivedGestational ageTotaln=528χ2 Value (df)p-value
00266*84*15261.33 (9)<0.001
1 - 241285*106*207
3 - 5327*5751138
> 5810*8531

n= 528; * p<0.001 using chi square test. Values in parenthesis expressed in percentages

According to the WHO ATC classification system 2013 (16th edition accessed on 19th October 2014) anti- infectives for systemic use (67.7%) have been most freqently prescribed, followed by drugs for the respiratory system (n= 157) and nervous system (n= 149) [Table/Fig-4].

Number of drug prescriptions in NICU according to WHO ATC Classification [10]

DrugsNo. of prescription (%)
Antiinfective for systemic use1123 (67.7)
Respiratory System157 (9.5)
Nervous system149 (9.0)
Cardiovascular System115 (6.0)
Alimentary tract52 (3.1)
Sytemic Hormonal preparations36 (2.1)
Others26 (1.6)

Among antibiotics Amikacin (n =187), Cefotaxime (n= 168) and Levofloxacin (n= 137) were the drugs most often prescribed [Table/Fig-5]. Antibiotic prescribing trends amongst preterm and term neonates revealed that there was statistically significant difference between the two groups (p<0.05). Amikacin and Cefotaxime were given more to term infants whereas other antibiotics (Levofloxacin, Pipercillin- tazobactum, Meropenem) were prescribed more to preterm neonates. (p<0.05) [Table/Fig-6].

List of the most frequently used systemic antibiotics

AntibioticsNo. of Prescriptions
Cefotaxime Sulbactam168
Piperacillin – Tazobactam112
Amoxycillin-Clavulanic Acid81

Antibiotics use with respect to gestational age

* p < 0.05 using chi square test

Amikacin and cefotaxime was prescribed to significantly more (p<0.05) number of outborn patients whereas Netilmycin and Amoxycillin-Clavulanic Acid were given more to inborn neonates (p<0.05). Along with these drugs, outborn sick patients also received Piperacillin-tazobactum, Meropenem, Vancomycin (p<0.05) [Table/Fig-7].

Antibiotics use in inborn and outborn neonates

DrugInborn(%)n=189Outborn (%)n=339Total (%)n=528χ2 test values(df)
Amikacin7.950.7#35.497.2 (1)p<0.001
Cefotaxime6.845.7#31.884.4 (1)p <0.001
Levofloxacin21.728.325.92.8 (1)p = 0.93 NS
Piperacillin– Tazobactam13.223.3#19.77.7 (1)p = 0.005
Netilmycin39.6#2.615.9127.6 (1)p < 0.001
Meropenem11.618.5#16.15.1 (1)p = 0.024
Amoxycilin-clavulanic acid38.1#2.615.3108.2 (1)p <0.001
Vancomycin6.915.6#12.58.5 (1)p = 0.004
Fluconazole1. (1)p = 0.064 NS
Metronidazole2.16.7#5.15.4 (1)p = 0.020
Colistin2. (1)p = 0.071 NS

# p<0.05 using chi square test


This study found that antibiotics were the most commonly prescribed drug class in neonates in a tertiary level NICU. The main aim of this study was to evaulate the prescribing pattern of antibiotics The majority of antibiotics showed highest exposure rates in infants with lower gestational age (<32 weeks) probably because of poor immunity, prolonged hospital stay and high risk of sepsis. [Table/Fig-2] shows 55.94% patients received between 1 to 2 antimicrobials, 30% patients had 3 to 5 antimicrobials prescribed, while 14.05% patients received 5 and above antimicrobials. Neubert et al., observed that 90.7% of all study patients were treated with antibiotics & mostly two antibiotics [11]. Within the group of very preterm infants 96.2% patients were treated with antibiotics [11]. These absolute numbers are in line with the data published from another hospital in Germany by Gortner et al., where the exposure to antibiotics in preterm neonates (24–29 weeks’ gestation) was 98.8% [12]. Similar high exposure numbers for antibiotics are reported from the USA & Italy [13,14]. The high rate of antibiotic exposure in our study is similar to previous studies carried out in India as well as other countries and is probably due to the standard practice of administering antibiotics pending bacterial culture results in sick neonates and is not a true reflection of the incidence of bacterial infection [1517]. A study by Fonseca et al., revealed that the highest use was in neonates with birth weight less than 1500 g and 92% of them received antibiotics within the first 48 hours after birth [18]. These findings may be explained by high susceptibility of neonates to bacterial infections, especially for very preterm neonates, who need intubation and mechanical ventilation. Clinical findings are usually variable, laboratory test (i.e. white blood cell count, C-reactive protein) are not highly sensitive and specific during the first hours following birth [19] which also accounts for the high rate of antibiotics treatment of neonates. As deleterious infections often become manifest without obvious clinical and laboratory signs, antibiotic treatment is indicated in sick neonates even if the clinical signs are only minimal. Among antimicrobials, Amikacin, Cefotaxime and Levofloxacin were the drugs most often prescribed. Amikacin and Cefotaxime were given more to term infants whereas higher antibiotics, Levofloxacin, Piperacillin-tazobactum and Meropenem were prescribed more to preterm neonates. Use of higher antibiotics mainly Levofloxacin, Vancomycin, Fluconazole, Metronidazole and Colistin was significantly more in patients with extreme preterm and very preterm babies. Amikacin, cefotaxime were most frequently used antimicrobials in previous Indian studies [16,20]. However, looking at individual drugs a great variation with regard to which drugs are used most frequently is apparent [11,13].

This heterogeneity indicates that empiric antibiotic treatment varies among different countries and in NICUs of the same country. This is because currently no standard guidelines regarding the choice of empiric antibiotics exist. This finding is not surprising as; Cochrane review comparing the antibiotic regimens for suspected late onset sepsis in newborn infants concluded that there is inadequate evidence from randomized trials in favour of any particular antibiotic regimen for the treatment of suspected late onset neonatal sepsis [21]. The choice of antibiotic regimes depends upon information regarding known flora prevalent in a unit, personal experience of neonatologist and culture reports rather than being guided by comparative clinical studies. Therefore, use of individual antibiotics could not be compared with other studies, as its use in respect to gestational age groups & outborn- inborn groups was not mentioned [13,20,22]. Decisions about how to prevent neonatal sepsis, who and how long to treat, and which antibiotics to use remain important clinical problems [23,24]. So, early sepsis evaluations and empiric antibiotic treatment is required [25]. In the present study, to give wider coverage, according to NICU antimicrobial policy, the out born neonates received Amikacin & cefotaxime as an empirical therapy, while Netilmycin & Amoxicillin- clavulanic acid was common among inborn neonates. This covers both gram positive and gram negative organisms. The microbial culture positive cases showed that the main organisms were Coagulase negative Staphylococcus, Enterococcus fecalis, Staphylococcus aureus. Antibiotics were changed to Levofloxacin, Piperacillin, Meropenem or Colistin according to culture and sensitivity reports. Since in our study, neonatal sepsis was predominantly present in preterm infants. So use of these higher antibiotics was significantly (p<0.001) more in preterm babies than term patients.


Few limitations of our study are, as study comprised most of the outborn population, drug history mainly antibiotics received by these neonates before admission could not be collected. Another limitation of our study is that data pertaining to drugs received by mother just prior or during delivery could not be revealed. This could have impact on antibiotic prescribing pattern, as symptomatic baby can have a false negative blood culture if antibiotics are given prenatally to the mother.


In present study, 28% of NICU patients were managed without any drug, 70.7% of neonates had received the antibiotic prescriptions and the maximum numbers of antibiotic prescriptions were found in the preterm and out born patients. The use of higher antibiotics was also more in out born sick infants. In spite of complicated neonates getting admitted to NICU, the number of drugs per prescription was not very high. Problems existed in more number of antibiotics prescribed, less use of generic drugs, the absence of the latest National essential list of medicines and high use of antimicrobial agents, not in line with culture reports. Present study suggests that Antibiotics policy to be framed & periodically reviewed: to reduce unnecessary use of antibiotics and associated problems.

@ Higher death rate was observed in these patients as compared to other patientsp<0.01using Chi-square test. Values in parenthesis are in percentagesn= 528; * p<0.001 using chi square test. Values in parenthesis expressed in percentages# p<0.05 using chi square test


[1]Shrestha R, Shrestha JM, Gurung B, Antibiotic usage and its sensitivity pattern in the NICU Kathmandu Univ Med J (KUMJ) 2012 10(38):27-32.  [Google Scholar]

[2]Moorthi C, Paul PR, Srinivasan A, Senthil CK, Irrational use of antibiotics in paediatric prescriptions: A pilot study at community pharmacy in Erode City Der Pharmacia Lettre 2011 3(3):171-77.  [Google Scholar]

[3]Paluck E, Katzentein D, Frankish CJ, Herbert CP, Milner R, Speert D, Prescribing practices and attitudes toward giving children antibiotics Can Fam Physician 2001 47:521-27.  [Google Scholar]

[4]Ashraf H, Handa S, Khan NA, Prescribing pattern of drugs in outpatient department of child care centre in Moradabad city International Journal of Pharmaceutical Sciences Review and Research 2010 3(2):001-05.  [Google Scholar]

[5]Walson PD, Paediatric clinical pharmacology and therapeutics. In: Speight TM, Holford NHG, eds. Avery’s Drug Treatment. Auckland ADIS International 1997 :127-223.  [Google Scholar]

[6]Viswanad V, Abraham S, Abraham A, Anupama PP, Muralidharan A, Arya SK, Confrontational Use Of Antibiotics In Pediatric Prescriptions Deccan J Pharmaceutics and Cosmetology 2010 1(2):52-56.  [Google Scholar]

[7]World Health Organization. WHO Model Formulary for Children 2010. Geneva: WHO, 2010. Available at (last accessed 26 August 2014)  [Google Scholar]

[8]Filius PMG, Liem TB, Vander LPD, Janknegt R, Natsch S, Vulto AG, An additional measure for quantifying antibiotic use in hospitals J Antimicrob Chemother 2005 55(5):805-08.  [Google Scholar]

[9]Bhartiy SS, Shinde M, Nandeshwar S, Tiwari SC, Pattern of prescribing practices in the Madhya Pradesh, India Kathmandu Univ Med J (KUMJ) 2008 6(1):55-9.  [Google Scholar]

[10]WHO Anatomical & Chemical Classification coding system (ATC/DDD Index) 2013. Available at (Last accessed on 19 July 2014)  [Google Scholar]

[11]Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W, Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis Eur J Clin Pharmacol 2010 66(1):87-95.  [Google Scholar]

[12]Gortner L, Bernsau U, Brand M, Drug utilization in very premature infants in neonatal intensive care units Dev Pharmacol Ther 1991 17(3–4):167-71.  [Google Scholar]

[13]Warrier I, Du W, Natarajan G, Salari V, Aranda J, Patterns of drug utilization in a neonatal intensive care unit J ClinPharmacol 2006 46(4):449-55.  [Google Scholar]

[14]Italian Collaborative Group on Preterm DeliveryEarly neonatal dmg utilization in pretenn newborns in neonatal intensive care units Developmental Pharmacology and Therapeutics 1998 11:1-7.  [Google Scholar]

[15]Vaniya HV, Agrawal JM, Patel NM, Trivedi HR, Balat JD, Jadav SP, Chawda DA, Antimicrobial drug utilization pattern in neonatal sepsis in a tertiary care hospital Journal of Clinical & Experimental Research 2014 2(2):110-14.  [Google Scholar]

[16]Patel Brijal S, KubavatAmita R, Sondarva Divyesh B, Piparva Kiran G, Drug Utilization Study In Neonatal Intensive Care Unit At Tertiary Care Hospital, Rajkot, Gujarat : A Prospective Study World Journal of Pharmacy and Pharmaceutical Sciences 2015 4(7):2034-42.  [Google Scholar]

[17]Stevenson DK, Verter J, Fanaroff AA, Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage Arch Dis Child Fetal Neonatal. Ed 2000 83:182-85.  [Google Scholar]

[18]Fonseca SN, Ehrenkranz RA, Baltimore RS, Epidemiology of antibiotic use in a neonatal intensive care unit Infect Control Hosp Epidemiol 1994 15(3):156-62.  [Google Scholar]

[19]Mathers N, Pohlandt F, Diagnositic audit of C-reactive protein in neonatal infection European journal of Pediatrics 1987 146:147-51.  [Google Scholar]

[20]Chatterjee S, Mandal A, Lyle N, Mukherjee S, Singh AK, Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India Pharmacoepidemiology and drug safety 2007 16:1141-45.  [Google Scholar]

[21]Gordon A, Jeffery HE, Antibiotic regimens for suspected late onset sepsis in newborn infants Cochrane Database Syst Rev 2005 (Issue 3):CD004501  [Google Scholar]

[22]Praveen K, Jennifer K Walker, Hurt KM, Medication use in the Neonatal intensive care unit current patterns and off lable use of parenteral medications J Pediatrics 2008 152(3):412-15.  [Google Scholar]

[23]American College of Obstetricians and GynecologistsACOG Committee Opinion: number 279, December 2002: prevention of early-onset group B streptococcal disease in newborns Obstet Gynecol 2002 100:1405-12.  [Google Scholar]

[24]American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and newbornRevised guidelines for prevention of early-onset group B streptococcal (GBS) infection Pediatrics 1997 99:489-96.  [Google Scholar]

[25]Alarcon A, Pena P, Salas S, Sancha M, Omenaca F, Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis Pediatr Infect Dis J 2004 23(4):295-99.  [Google Scholar]